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The neuropeptide vasopressin is a key molecular mediator of social behavior in animals and humans, implicated in anxiety and
autism. Social recognition, the ability to assess the familiarity of others, is essential for appropriate social interactions and
enhanced by vasopressin; however, the neural mechanisms mediating this effect in humans are unknown. Using functional
magneticresonanceimaging(fMRI)andanimplicitsocialrecognitionmatchingtask,weemployedadouble-blindedprocedurein
which 20 healthy male volunteers self-administered 40 UI of vasopressin or placebo intranasally, 45min before performing the
matching task in the scanner. In a random-effects fMRI analysis, we show that vasopressin induces a regionally speciﬁc
alterationina key nodeof the theory of mindnetwork,the left temporoparietaljunction, identifying a neurobiological mechanism
for prosocial neuropeptide effects in humans that suggests novel treatment strategies.
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Introduction
Social recognition is a cornerstone of social cognition; the
ability to properly and quickly assess the familiarity of others is
essential for appropriate and beneﬁcial social interactions.
Vasopressin, a neuropeptide released in the brain that has
been implicated in anxiety and autism,
1 is a known molecular
mediator of complex social behaviors, including social
recognition.
2,3 Speciﬁcally, centrally injected vasopressin in
rats improves and prolongs social memory,
4 whereas vaso-
pressin receptor knockout
5 and antagonism
6 impairs social
recognition, but not general object recognition. In agreement
with these data in animals, intranasal administration of
vasopressin in human males has been shown to enhance
familiarity ratings of previously seen emotional faces.
7
In rodents, the lateral septum is especially implicated in the
action of vasopressin, through V1a receptors, to inﬂuence
social recognition. Re-expressing V1a receptors speciﬁcally
in the lateral septum of V1aR knockout mice completely
rescues social recognition, and overexpression of the
vasopressin V1a receptor in the lateral septum of wild-type
mice potentiates social recognition.
8 The lateral septum is
densely connected to the olfactory system in rodents,
9 where
social memory primarily relies on olfactory cues, while social
recognition in primates, including humans, is driven by visual
and auditory information. In agreement with this, social
familiarity in humans has been primarily linked to cortical
areas with access to multimodal visual/auditory information,
such as posterior superior temporal cortex/temporoparietal
junction (TPJ) and prefrontal cortex,
10–12 suggesting that
these regions may contribute to the (currently unknown)
neural circuitry underlying the inﬂuence of vasopressin on
social recognition in humans.
To test this hypothesis, in this study, using functional
magnetic resonance imaging (fMRI) and an implicit social
recognition matching task, we assessed the effect of
vasopressin on social familiarity-related neural activity in
men to determine the brain region(s) underlying the inﬂuence
of vasopressin on social recognition in humans.
Materials and methods
Participants. A total of 20 right-handed, Caucasian, healthy
male volunteers aged 18–43 years (mean age¼28.60 years,
s.d.¼5.88) participated in the study. Volunteers were
recruited from the Washington DC Metropolitan Area and
the National Institutes of Health community. Participants had
no structural brain abnormalities, no history of psychiatric or
neurological disorders and had normal electrocardiograms
and blood pressure. Each participant gave written, informed
consent for a protocol approved by the National Institute of
Mental Health institutional review board.
Emotion inventories. Both before and after each of the
scanning sessions, the current emotional states of the
participants were assessed with the state versions of the
State-Trait Anger Expression Inventory
13 and State-Trait
Anxiety Inventory
14 to determine potential effects of
vasopressin on current levels of anger and anxiety,
respectively. Valence, arousal and dominance was also
assessed before and after the scanning sessions using the
Self-Assessment Manikin.
15 Potential drug effects on each
rating questionnaire were statistically determined using
paired t-tests.
Implicit social recognition matching task. The implicit
social recognition matching task used was a modiﬁed version
of a block-design matching task,
16 consisting of blocks
matching negative emotional facial expressions and blocks
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www.nature.com/tpmatching negative scene orientations as a non-social control
condition—as part of a neuroimaging task battery. Subjects
performed two sequential runs of the task. In both runs, the
face stimuli were from the NimStim Face Stimulus Set (http://
www.macbrain.org/resources.htm), and the scene stimuli
were from the International Affective Picture System (http://
csea.phhp.uﬂ.edu/media/iapsmessage.html). The ﬁrst run
(4.17min) served as training in which subjects were
familiarized with two faces and two scenes that were
repeatedly presented in the matching task. This training run
was divided into ten blocks, ﬁve blocks of matching two faces
with fearful/angry facial expressions and ﬁve blocks of
matching orientation of two scenes as a non-social control
condition, alternatively. Each block began with a 2-s
instruction screen and consisted of four matching frames
(5s each); for each matching frame, participants indicated
which of the two bottom images, left or right, match the
center-top image. In the second run (eight blocks: four face-
matching blocks and four scene-matching blocks; 3.43min),
subjects performed the same task as the ﬁrst run and were
again presented with blocks of matching the familiar faces
and scenes, but intermixed with blocks of matching
unfamiliar faces and scenes (Figure 1). Two of the four
matching blocks of faces and scenes used repeatedly
previously seen (‘familiar’) stimuli, whereas in the other
blocks, never before seen (‘unfamiliar’) stimuli were used.
Subjects performed this task (both runs) in two separate
sessions, at 1 week interval, and self-administered either 40
UI of vasopressin or placebo intranasally under investigator
supervision (double-blind) in each session, 45min before
beginning the task to capture peak CSF vasopressin levels.
17
The drug order (vasopressin or placebo) was counter-
balanced across subjects. The Pharmaceutical Development
Section of the NIH Pharmacy Department formulated the
vasopressin and placebo solutions and maintained the blind.
fMRI and behavioral data are only reported for the second run
of the task, as the ﬁrst run served solely as training to acquire
stimuli familiarity. Potential drug effects on task performance
were statistically determined using paired t-tests and re-
peated-measures analysis of variance.
fMRI imaging. Scanning was performed on a 3T GE Signa
scanner (GE Healthcare, Milwaukee, WI, USA). fMRI data is
only reported for the second run of the social recognition
matching task, as the ﬁrst run served solely as training to
acquire stimuli familiarity. For each participant, 98 whole-
brain scans were acquired to measure the T2*-weighted
blood oxygenation level-dependent effect with the following
parameters: gradient-recall echo planar imaging;
TR¼2000ms; TE¼30ms; ﬂip angle¼901;6 4  64 matrix;
FOV¼240mm; and 28 slices (3.5-mm thick) acquired with
an interleaved order of slice acquisition. Five additional
scans were acquired at the beginning of run to allow for
steady-state magnetization (discarded from analysis). Head
movement during scanning was minimized with a vacuum
pillow and additional padding.
fMRI preprocessing. fMRI preprocessing was performed
using Statistical Parametric Mapping (SPM5) (http://
www.ﬁl.ion.ucl.ac.uk/spm/). Motion correction to the ﬁrst
functional scan was performed using a six-parameter rigid-
body transformation. For each individual, the mean of the
functional images was spatially normalized to the Montreal
Neurological Institute template conforming to the Talairach
orientation system
18 by applying a 12-parameter afﬁne
transformation followed by nonlinear warping.
19 The
computed transformation parameters were applied to all
the functional images, interpolated to a ﬁnal voxel size
of 3 3 3mm
3. Images were subsequently spatially
smoothed with an 8-mm Gaussian kernel.
fMRI analysis. A random-effects, epoch-related statistical
analysis was performed in a two-level procedure using
SPM5. At the ﬁrst level, a separate general linear model
was speciﬁed for each participant for each session. Blood
oxygenation level-dependent responses during each face-
matching block (unfamiliar and familiar) and each scene-
matching block (unfamiliar and familiar) were modeled
separately, by convolving the block onset vectors with a
synthetic hemodynamic response function. The data were
high-pass ﬁltered (128-s cutoff) to remove low-frequency
Figure 1 Schematic diagram of the social recognition matching task. The task was divided into eight blocks, four blocks of matching faces with fearful and angry facial
expressions, from the NimStim Face Stimulus Set (http://www.macbrain.org/resources.htm), and four blocks of matching scene orientation, from the International Affective
Picture System (http://csea.phhp.uﬂ.edu/media/iapsmessage.html), as a non-social control condition. Two of the four matching blocks of faces and scenes used repeatedly
previously seen (‘familiar’) stimuli, whereas in other blocks, never before seen (‘unfamiliar’) stimuli were used. Each block contained four matching panels (5s each) and
participants indicated which of the two bottom images, left or right, match with the center-top image. Instructions were displayed for 2s at the beginning of each block: ‘Match
Emotion’ or ‘Match Pictures’.
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autoregressive model of the ﬁrst order. To isolate effects of
social recognition, contrast images were calculated for each
participant in both sessions for the interaction of sociality
and familiarity ((faces–scenes) (familiar–unfamiliar)). The
individual contrast images were then entered into a second
level random-effects analysis in which a paired t-test was
used to statistically assess drug effects (vasopressin versus
placebo) on resulting neural activity. A cluster-based, whole-
brain family-wise error-corrected threshold of Po0.05 was
applied to the resulting summary statistical maps using
parameters determined by the Monte Carlo simulations
implemented in the AlphaSim program in AFNI.
20 The
simulations (1000 iterations, 8mm full width at half
maximum, 3 3 3mm
3 voxels) yielded a combined
threshold of t¼3 and cluster extent of 35 contiguous voxels
(945mm
3) as equivalent to a corrected threshold of Po0.05.
Results
Behavioral results. The task performance data are given in
Table 1. Task performance data were not available for one
subject because of technical difﬁculties. Participants
performed the task with near-perfect accuracy, and there
was no signiﬁcant effect of drug on accuracy (t¼0.33;
P¼0.75). Across sessions (vasopressin and placebo), there
was a main effect of familiarity and sociality on reaction time
periods; participants responded signiﬁcantly faster when
matching familiar stimuli (F(1,36)¼260.71; Po0.001) and
faster during face-matching blocks compared with scenes
(F(1,36)¼148.57; Po0.001). There was no effect of drug
(F(1,36)¼0.63; P¼0.43).
Behavioral data from the pre- and post-scan emotional
inventories are given in Table 2. The level of experienced
arousal in both conditions (vasopressin and placebo) was
signiﬁcantly greater post-scan compared with pre-scan
(placebo: t¼2.45, P¼0.02; vasopressin: t¼2.35, P¼0.03).
No other emotional measures (valence, dominance, anger
and anxiety levels) differed signiﬁcantly between pre- and
post-scan in either condition (P40.10). As reported pre-
viously,
21 vasopressin had no signiﬁcant effect on any
behavioral measurements of valence, arousal, dominance,
anger or anxiety ratings (P40.10).
fMRI results. Vasopressin induced a regionally speciﬁc
alteration in social recognition-related activity solely in the
left TPJ/Brodmann area 39 (peak:  48,  66, 21; t¼4.81;
k¼52; Po0.05 corrected; Figure 2a), as demonstrated by
the effect of drug compared with placebo on the interaction
of sociality (faces or scenes) and familiarity (familiar or
unfamiliar). Paired t-tests performed on beta values
extracted from the peak voxel ( 48,  66, 21) revealed that
under placebo, activity in left TPJ was signiﬁcantly increased
by social unfamiliarity, that is, unfamiliar faces, compared
with unfamiliar scenes (t¼3.42; P¼0.003), an effect that
vanished for familiar stimuli (t¼0.05, P¼0.96), and under
vasopressin (Figure 2b); after vasopressin, social
unfamiliarity did not differentially inﬂuence TPJ activation
(t¼0.75; P¼0.46) and was statistically comparable to the
activation for familiar faces, compared with scenes under
placebo (t¼0.42; P¼0.68). Although it does not survive
statistical signiﬁcance, there is also a trend for an increase in
left TPJ activity to familiar social compared with non-social
stimuli under vasopressin (t¼1.99; P¼0.062).
Table 1 Task performance data
Placebo Vasopressin
Unfamiliar
faces
Familiar
faces
Unfamiliar
scenes
Familiar
scenes
Unfamiliar
faces
Familiar
faces
Unfamiliar
scenes
Familiar
scenes
Accuracy
(% correct)
100.0 (0.0) 99.34 (2.87) 95.39 (7.46) 99.34 (2.87) 100.0 (0.0) 99.34 (2.87) 96.05 (7.28) 99.34 (2.87)
Reaction time
(s)
1.43 (0.31) 1.25 (0.30) 2.10 (0.41) 1.55 (0.39) 1.36 (0.25) 1.15 (0.26) 2.06 (0.38) 1.48 (0.22)
Faces: data from the face-matching blocks. Scenes: data from the scene-matching blocks. Mean data are given (standard deviation in parenthesis).
N¼19; task performance data for one subject were not available.
Table 2 Behavioral data from emotion inventories
Placebo Vasopressin
Pre Post Post–Pre Pre Post Post–Pre
STAI-S 27.47 (6.36) 25.90 (4.53)  1.95 (5.83) 27.55 (6.63) 27.16 (6.41)  0.79 (5.10)
STAXI-S 15.30 (0.66) 15.10 (0.31)  0.20 (0.77) 15.45 (1.23) 15.40 (0.88)  0.05 (0.69)
SAM: valence 2.80 (1.24) 2.85 (1.04) 0.05 (1.15) 2.85 (1.27) 3.15 (0.99) 0.30 (1.38)
SAM: arousal
a 6.20 (1.61) 6.95 (1.36) 0.75 (1.37) 5.75 (1.48) 6.65 (1.81) 0.90 (1.71)
SAM: dominance 5.45 (1.57) 5.75 (1.45) 0.30 (1.08) 5.90 (1.71) 5.90 (1.07) 0.00 (1.38)
Abbreviations: SAM, self-assessment manikin; STAI-S, State-Trait Anxiety Inventory-State version; STAXI-S, State-Trait Anger Expression Inventory-State version.
aArousal post-scan levels were signiﬁcantly different from pre-scan levels in both the placebo (P¼0.02) and vasopressin conditions (P¼0.03).
Mean data are given (standard deviation in parenthesis).
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Our ﬁndings demonstrate that vasopressin modulates social
recognition-related activity in the left TPJ in humans. During
exposure to socially unfamiliar stimuli, vasopressin abolishes
the augmentation of left TPJ activity evoked by social
unfamiliarity under placebo to a level comparable to that
evoked by socially familiar stimuli under placebo. As such,
these data suggest that, when unfamiliar faces are processed
(matched) under vasopressin, stimuli are more readily
transferred to a familiar categorization, as represented in
TPJ reactivity. The TPJ has been implicated in the processing
of social background context and social familiarity
22 and
accesses multimodal visual/auditory information that drive
social recognition in primates, including humans.
10–12 Con-
versely, in rodents, the lateral septum, connected to the
olfactory system, is a critical site of action for vasopressin to
inﬂuence social recognition.
8 The absence of differential
activation in the lateral septum, while not excluding an effect
in humans (as this structure is difﬁcult to image in human
brain), could therefore be related to species differences.
VasopressinislikelyactingonvasopressinV1areceptorsin
the brain to inﬂuence familiarity of social stimuli;
8 however,
although V1a receptors are evident in various primate brain
regions,
23 it remains unclear if they exist in the human TPJ.
Therefore, whether vasopressin is acting directly or by an
indirectpathwaytoinﬂuencesocialrecognition-relatedactivity
in the left TPJ remains to be elucidated.
In previous work, the directionality of the relationship
between TPJ activity and social familiarity has been incon-
sistent(thatis,activityenhancedbysocialfamiliarityoractivity
enhanced by social unfamiliarity). Such discrepancies may be
dependent on whether familiar stimuli were newly learned,
22
as here, or personally familiar
11 (for example, relatives).
Future work should determine whether our vasopressin
ﬁnding extends to personally familiar faces. The TPJ is also
a critical brain structure associated with human-speciﬁc social
cognition,
12 notably involved in ‘theory of mind’ processes,
24
suggesting further studies of vasopressin effects on these
aspects of social cognition as well.
Given the prominent role of the TPJ in social-speciﬁc
cognition,theTPJactivationtounfamiliarfacesunderplacebo
may represent the social relevance or importance of these
stimuli, relative to non-social or familiar stimuli. As such,
based on the current ﬁndings, vasopressin may inﬂuence
social recognition by modulating left TPJ activity to dampen
the social importance of unfamiliar faces while potentially
(evident by trend in TPJ activity increase) enhancing the
social importance of familiar faces.
Behaviorally, vasopressin did not inﬂuence the emotion
inventories or task performance. This lack of behavioral
modiﬁcation is consistent with previous studies in which
participants performed a comparable matching paradigm—
but without manipulating social familiarity—after administra-
tion of vasopressin
21 and the related neuropeptide, oxyto-
cin
25, and is likely due to the implicit nature of the task (that is,
subjects were not explicitly tested on social recognition).
Alternatively, it is possible that the lack of a signiﬁcant
inﬂuence of drug on task performance is due to a ceiling
effect; therefore, implementation of a more challenging task
could reveal vasopressin effects on task performance
accompanying the reported drug-induced modiﬁcation of
neural activity.
We note that behaviorally, both oxytocin
26 and vasopres-
sin
7 have been shown to increase the familiarity of faces,
suggestingthatthiscouldbeajointmechanismsupportingthe
prosocial action of these neuropeptides. On the basis of this
study, it should be investigated whether familiarity after
oxytocin administration is also mediated through the TPJ or
rather, as previous researchers have proposed,
26 through an
amygdala–fusiform face area circuit.
In conclusion, to our knowledge, this is the ﬁrst study to
investigate the neural biology underlying the effect of
vasopressin on social recognition in humans, and our data
identify the ﬁrst regionally speciﬁc pharmacological strategy
targeting the TPJ, suggesting that vasopressin receptors
could be present in human cortex or action through an as yet
unspeciﬁed indirect pathway. Our results implicate a neuro-
biological mechanism by which vasopressin may enhance
social familiarity by modulating the TPJ and open a
pharmacological approach to target this region in psychiatric
disorders with known social cognitive deﬁcits such as autism
and social anxiety disorder.
Figure 2 The effect of vasopressin compared with placeboon the interaction of
sociality (faces/scenes) and familiarity (familiar/unfamiliar) revealed (a) a signiﬁcant
activation in the left temporoparietal junction, overlaid on a sagittal section of a
structural template MRI (x¼ 48). The color bar represents t-values. (b) Plotted
are the contrast estimates extracted from the peak-activated voxel ( 48,  66, 21).
Bars represent means across subjects and error bars represent standard error.
Under placebo (blue bars), contrast estimates were signiﬁcantly greater for
unfamiliar faces compared with unfamiliar scenes (*P¼0.003), an effect that was
abolished by stimulus familiarity and vasopressin (red bars) administration.
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